| Financial Year |
March 31 2020 |
| Monetary Funds |
217,084,048.92 |
| Held-for-trading Financial Assets |
191,691,333.99 |
| Notes Receivable |
135,501,637.72 |
| Accounts Receivable |
247,678,378.89 |
| Advances to Suppliers |
1,405,431,232.53 |
| Other Receivables |
1,234,828,468.91 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
78,661,754.89 |
| Dividend Receivable |
-- |
| Inventories |
816,037,917.71 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
2,599,671.84 |
| Other Current Assets |
116,149,917.66 |
| Total Current Assets |
4,367,002,608.17 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
480,136,969.89 |
| Investment Properties |
191,807,298.44 |
| Fixed Assetes |
283,919,981.99 |
| Under-construction Projects |
15,876,814.76 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
7,396,935,998.09 |
| Intangible Assets |
142,066,022.44 |
| R&D expenses |
-- |
| Goodwill |
370,926.19 |
| Long-Term Deferred and Prepaid Expenses |
11,381,987.12 |
| Deferred Income Tax Assets |
303,514,667.17 |
| Other Non-Current Assets |
70,197,246.05 |
| Sub-Total of Non-Current Assets |
9,900,233,286.69 |
| Total Assets |
14,267,235,894.86 |
| Short-Term Loans |
1,097,010,226.44 |
| Trading Financial liabilities |
-- |
| Notes Payable |
91,539,312.36 |
| Accounts Payable |
480,569,184.43 |
| Accounts Received In Advance |
1,175,603,455.23 |
| Employee Compensation Payable |
10,829,706.78 |
| Taxes Payable |
409,812,320.34 |
| Interest Payable |
2,589,243.05 |
| Dividend Payable |
-- |
| Other payables |
579,028,138.87 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
898,406,300.87 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
4,742,798,645.32 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
24,940,977.03 |
| Deferred Income Tax Liabilities |
11,478,267.89 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
37,510,875.18 |
| Total Liabilities |
4,780,309,520.50 |
| Paid-In Capital(Or Share Stock) |
3,576,488,773.00 |
| Capital Surplus |
6,403,822,519.79 |
| Surplus Reserve |
218,126,219.90 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,112,468,958.77 |
| Minority Stockholder's Interest |
289,105,840.15 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,197,820,534.21 |
| Owner's Equity（Stockholder's Equity） |
9,486,926,374.36 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,267,235,894.86 |
